Table of Content

1 Executive Summary
1.1 Market Attractiveness Analysis
1.1.1 Global Montelukast API Market, By Application
1.1.2 Global Montelukast API Market, By Region
2 Market Introduction
2.1 Definition
2.2 Scope of the Study
2.3 Market Structure
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
3.6 List of Assumptions
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Increasing Incidence of Asthma
4.3 Restraints
4.3.1 Availability of Substitutes and Adverse Effects Associated with Montelukast
4.4 Opportunities
4.4.1 Opportunities Associated with the Technological Advancements
5 Market Factor Analysis
5.1 Supply Chain Analysis
5.1.1 Research and Development
5.1.2 Production
5.1.3 Distribution & Sale
5.1.4 Post-Sale Review
5.2 Porter’s Five Forces Model
5.2.1 Threat of New Entrants
5.2.2 Intensity of Rivalry
5.2.3 Threat of Substitutes
5.2.4 Bargaining Power of Suppliers
5.2.5 Bargaining Power of Buyers
5.3 Regulatory Scenario
5.4 Pipeline Analysis
5.4.1 Introduction
5.4.2 Montelukast 10 mg Tablet
5.4.3 Montelukast Chewable 5 mg Tablets
5.4.4 Montelukast buccal film
5.4.5 Montelukast 10mg
5.5 Pricing Evolution
5.6 Patent Analysis
5.6.1 Overview
6 Global Montelukast API Market, by Application
6.1 Introduction
6.2 Asthma
6.3 Allergic Rhinitis
6.4 Bronchospasm
6.5 Urticaria
6.6 Others
7 Global Montelukast API Market, by Region
7.1 Introduction
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Latin America
7.4 Europe
7.4.1 Spain
7.4.2 France
7.4.3 UK
7.4.4 Germany
7.4.5 Italy
7.4.6 Eastern Europe
7.4.7 Rest of Europe
?
7.5 Asia-Pacific
7.5.1 China
7.5.2 India
7.5.3 Japan
7.5.4 Rest of Asia-Pacific
7.6 The Middle East and Africa
7.6.1 Middle East
7.6.2 Africa
8 Competitive Landscape
8.1 Introduction
8.2 Key Development Analysis
9 Company Profiles
9.1 Merck Sharp & Dohme Corp
9.1.1 Financial Overview
9.1.2 Products/Services Offered
9.1.3 Key Developments
9.1.4 SWOT Analysis
9.1.5 Key Strategies
9.2 Dr. Reddy’s Laboratories Ltd
9.2.1 Financial Overview
9.2.2 Products/Services Offered
9.2.3 Key Developments
9.2.4 SWOT Analysis
9.2.5 Key Strategies
9.3 Morepen Laboratories Ltd
9.3.1 Financial Overview
9.3.2 Products/Services Offered
9.3.3 Key Developments
9.3.4 SWOT Analysis
9.3.5 Key Strategies
9.4 Mylan N.V.
9.4.1 Financial Overview
9.4.2 Products/Services Offered
9.4.3 Key Developments
9.4.4 SWOT Analysis
9.4.5 Key Strategies
9.5 Teva Pharmaceutical Industries Ltd
9.5.1 Financial Overview
9.5.2 Products/Services Offered
9.5.3 Key Developments
9.5.4 SWOT Analysis
9.5.5 Key Strategies
9.6 Hikma Pharmaceuticals PLC
9.6.1 Financial Overview
9.6.2 Products/Services Offered
9.6.3 Key Developments
9.6.4 SWOT Analysis
9.6.5 Key Strategies
9.7 Glenmark
9.7.1 Financial Overview
9.7.2 Products/Services Offered
9.7.3 Key Developments
9.7.4 SWOT Analysis
9.7.5 Key Strategies
9.8 Sandoz International GmbH
9.8.1 Financial Overview
9.8.2 Products/Services Offered
9.8.3 Key Developments
9.8.4 SWOT Analysis
9.8.5 Key Strategies
9.9 Vintage Pharmaceuticals Inc
9.9.1 Financial Overview
9.9.2 Products/Services Offered
9.9.3 Key Developments
9.9.4 SWOT Analysis
9.9.5 Key Strategies
?
9.1 Hetero
9.10.1 Financial Overview
9.10.2 Products/Services Offered
9.10.3 Key Developments
9.10.4 SWOT Analysis
9.10.5 Key Strategies
9.11 Aurobindo Pharma
9.11.1 Financial Overview
9.11.2 Products/Services Offered
9.11.3 Key Developments
9.11.4 SWOT Analysis
9.11.5 Key Strategies
10 Conclusion
10.1 Key Findings



List of Figures



FIGURE 1 MARKET SYNOPSIS
FIGURE 2 GLOBAL MONTELUKAST API MARKET ANALYSIS BY REGION
FIGURE 3 GLOBAL MONTELUKAST API MARKET: MARKET STRUCTURE
FIGURE 4 RESEARCH PROCESS FOR MRFR
FIGURE 5 TOP-DOWN & BOTTOM-UP APPROACH
FIGURE 6 MARKET DYNAMICS OVERVIEW
FIGURE 7 DRIVERS IMPACT ANALYSIS
FIGURE 8 RESTRAINTS IMPACT ANALYSIS
FIGURE 9 SUPPLY CHAIN: GLOBAL MONTELUKAST API MARKET
FIGURE 10 PORTER’S FIVE FORCES ANALYSIS OF THE GLOBAL MONTELUKAST API MARKET
FIGURE 11 GLOBAL MONTELUKAST API MARKET, BY APPLICATION, 2016–2023 (USD THOUSAND)
FIGURE 12 GLOBAL MONTELUKAST API MARKET, BY APPLICATION, 2016–2023 (TONS)
FIGURE 13 GLOBAL MONTELUKAST API MARKET, BY REGION, 2017 (VALUE %)
FIGURE 14 GLOBAL MONTELUKAST API MARKET BY REGION, 2016–2023 (TONS)

 

List of Tables



TABLE 1 LIST OF ASSUMPTIONS
TABLE 2 ATORVASTATIN API MARKET: PIPELINE ANALYSIS
TABLE 3 PRICING EVOLUTION (2015–2018), BY REGION (USD PER KG)
TABLE 4 PATENT ANALYSIS FOR THE GLOBAL DULOXETINE API MARKET
TABLE 5 GLOBAL MONTELUKAST API, BY APPLICATION, 2016–2023 (USD THOUSAND)
TABLE 6 GLOBAL MONTELUKAST API MARKET, BY APPLICATION, 2016–2023 (TONS)
TABLE 7 GLOBAL MONTELUKAST API MARKET FOR ASTHMA, BY REGION, 2016–2023 (USD THOUSAND)
TABLE 8 GLOBAL MONTELUKAST API MARKET FOR ASTHMA, BY REGION, 2016–2023 (TONS)
TABLE 9 GLOBAL MONTELUKAST APIMARKET FOR ALLERGIC RHINITIS, BY REGION, 2016–2023 (USD THOUSAND)
TABLE 10 GLOBAL MONTELUKAST API MARKET FOR ALLERGIC RHINITIS, BY REGION, 2016–2023 (TONS)
TABLE 11 GLOBAL MONTELUKAST API MARKET FOR BRONCHOSPASM, BY REGION, 2016–2023 (USD THOUSAND)
TABLE 12 GLOBAL MONTELUKAST APIMARKET FOR BRONCHOSPASM, BY REGION, 2016–2023 (TONS)
TABLE 13 GLOBAL MONTELUKAST API MARKET FOR URTICARIA, BY REGION, 2016–2023 (USD THOUSAND)
TABLE 14 GLOBAL MONTELUKAST APIMARKET FOR URTICARIA, BY REGION, 2016–2023 (TONS)
TABLE 15 GLOBAL MONTELUKAST API MARKET FOR OTHERS, BY REGION, 2016–2023 (USD THOUSAND)
TABLE 16 GLOBAL MONTELUKAST API MARKET FOR OTHERS, BY REGION, 2016–2023 (TONS)
TABLE 17 GLOBAL MONTELUKAST API MARKET, BY REGION, 2016–2023 (USD THOUSAND)
TABLE 18 GLOBAL MONTELUKAST API MARKET, BY REGION, 2016–2023 (TONS)
TABLE 19 GLOBAL MONTELUKAST API MARKET, BY APPLICATION, 2016–2023 (USD THOUSAND)
TABLE 20 GLOBAL MONTELUKAST API MARKET, BY APPLICATION, 2016–2023 (TONS)
TABLE 21 NORTH AMERICA MONTELUKAST API MARKET, BY COUNTRY, 2016–2023 (USD THOUSAND)
TABLE 22 NORTH AMERICA MONTELUKAST APIMARKET, BY COUNTRY, 2016–2023 (TONS)
TABLE 23 NORTH AMERICA MONTELUKAST API MARKET, BY APPLICATION, 2016–2023 (USD THOUSAND)
TABLE 24 NORTH AMERICA MONTELUKAST API MARKET, BY APPLICATION, 2016–2023 (TONS)
TABLE 25 U.S. MONTELUKAST API MARKET, BY APPLICATION, 2016–2023 (USD THOUSAND)
TABLE 26 U.S. MONTELUKAST APIMARKET, BY APPLICATION, 2016–2023 (TONS)
TABLE 27 CANADA MONTELUKAST APIMARKET, BY APPLICATION, 2016–2023 (USD THOUSAND)
TABLE 28 CANADA MONTELUKAST APIMARKET, BY APPLICATION, 2016–2023 (TONS)
TABLE 29 LATIN AMERICA MONTELUKAST API MARKET, BY APPLICATION, 2016–2023 (USD THOUSAND)
TABLE 30 LATIN AMERICA MONTELUKAST API MARKET, BY APPLICATION, 2016–2023 (TONS)
TABLE 31 EUROPE MONTELUKAST API MARKET, BY COUNTRY, 2016–2023 (USD THOUSAND)
TABLE 32 EUROPE MONTELUKAST API MARKET, BY COUNTRY, 2016–2023 (TONS)
TABLE 33 EUROPE MONTELUKAST API MARKET, BY APPLICATION, 2016–2023 (USD THOUSAND)
TABLE 34 EUROPE MONTELUKAST API MARKET, BY APPLICATION, 2016–2023 (TONS)
TABLE 35 SPAIN MONTELUKAST API MARKET, BY APPLICATION, 2016–2023 (USD THOUSAND)
TABLE 36 SPAIN MONTELUKAST API MARKET, BY APPLICATION, 2016–2023 (TONS)
TABLE 37 FRANCE MONTELUKAST API MARKET, BY APPLICATION, 2016–2023 (USD THOUSAND)
TABLE 38 FRANCE MONTELUKAST API MARKET, BY APPLICATION, 2016–2023 (TONS)
TABLE 39 UK MONTELUKAST APIMARKET, BY APPLICATION, 2016–2023 (USD THOUSAND)
TABLE 40 UK MONTELUKAST APIMARKET, BY APPLICATION, 2016–2023 (TONS)
TABLE 41 GERMANY MONTELUKAST API MARKET, BY APPLICATION, 2016–2023 (USD THOUSAND)
TABLE 42 GERMANY MONTELUKAST API MARKET, BY APPLICATION, 2016–2023 (TONS)
TABLE 43 ITALY MONTELUKAST API MARKET, BY APPLICATION, 2016–2023 (USD THOUSAND)
TABLE 44 ITALY MONTELUKAST API MARKET, BY APPLICATION, 2016–2023 (TONS)
TABLE 45 EASTERN EUROPE MONTELUKAST API MARKET, BY APPLICATION, 2016–2023 (USD THOUSAND)
TABLE 46 EASTERN EUROPE MONTELUKAST API MARKET, BY APPLICATION, 2016–2023 (TONS)
TABLE 47 REST OF EUROPE MONTELUKAST API MARKET, BY APPLICATION, 2016–2023 (USD THOUSAND)
TABLE 48 REST OF EUROPE MONTELUKAST API MARKET, BY APPLICATION, 2016–2023 (TONS)
TABLE 49 ASIA-PACIFIC MONTELUKAST API MARKET, BY COUNTRY, 2016–2023 (USD THOUSAND)
TABLE 50 ASIA-PACIFIC MONTELUKAST API MARKET, BY COUNTRY, 2016–2023 (TONS)
TABLE 51 ASIA-PACIFIC MONTELUKAST API MARKET, BY APPLICATION, 2016–2023 (USD THOUSAND)
TABLE 52 ASIA-PACIFIC MONTELUKAST API MARKET, BY APPLICATION, 2016–2023 (TONS)
TABLE 53 CHINA MONTELUKAST API MARKET, BY APPLICATION, 2016–2023 (USD THOUSAND)
TABLE 54 CHINA MONTELUKAST APIMARKET, BY APPLICATION, 2016–2023 (TONS)
TABLE 55 INDIA MONTELUKAST API MARKET, BY APPLICATION, 2016–2023 (USD THOUSAND)
TABLE 56 INDIA MONTELUKAST API MARKET, BY APPLICATION, 2016–2023 (TONS)
TABLE 57 JAPAN MONTELUKAST API MARKET, BY APPLICATION, 2016–2023 (USD THOUSAND)
TABLE 58 JAPAN MONTELUKAST APIMARKET, BY APPLICATION, 2016–2023 (TONS)
TABLE 59 REST OF ASIA-PACIFIC MONTELUKAST API MARKET, BY APPLICATION, 2016–2023 (USD THOUSAND)
TABLE 60 REST OF ASIA-PACIFIC MONTELUKAST API MARKET, BY APPLICATION, 2016–2023 (TONS)
TABLE 61 THE MIDDLE EAST AND AFRICA MONTELUKAST API MARKET, BY REGION, 2016–2023 (USD THOUSAND)
TABLE 62 THE MIDDLE EAST AND AFRICA MONTELUKAST API MARKET, BY REGION, 2016–2023 (TONS)
TABLE 63 THE MIDDLE EAST AND AFRICA MONTELUKAST API MARKET, BY APPLICATION, 2016–2023 (USD THOUSAND)
TABLE 64 THE MIDDLE EAST AND AFRICA MONTELUKAST APIMARKET, BY APPLICATION, 2016–2023 (TONS)
TABLE 65 MIDDLE EAST MONTELUKAST API MARKET, BY APPLICATION, 2016–2023 (USD THOUSAND)
TABLE 66 MIDDLE EAST MONTELUKAST API MARKET, BY APPLICATION, 2016–2023 (TONS)
TABLE 67 AFRICA MONTELUKAST APIMARKET, BY APPLICATION, 2016–2023 (USD THOUSAND)
TABLE 68 AFRICA MONTELUKAST APIMARKET, BY APPLICATION, 2016–2023 (TONS)
TABLE 69 KEY DEVELOPMENTS OVERVIEW